BLACK WEEKSInjektiopullot −15 % · kitit −10 % · muut −5 %koodillaIlmainen toimitus Saksaan alk. €200

Tämä sivu on käännetty automaattisesti, ja siinä voi olla virheitä. Onko suomi äidinkielesi? Otamme mielellämme vastaan palautetta ja korjauksia.Lähetä palautetta

The Peptide Desk The Peptide Desk
Dutasteride, tuotekuva

Laboratorioraportti

PDF
Testattu
Testattu
Dutasteride 1mg × 100 Tabs
Laboratorio
Analiza Białek
Päivämäärä
October 2026
Tulos
1.02 mg per tablet (1 mg label)
Tilauksen nro
Salasana

Testattu riippumattomasti, tarkistettavissa salasanalla suoraan laboratoriossa.

Hair & Skin

Dutasteride

Hair & Skin

Tilaus

Kappalehinta - Ilmainen toimitus Saksaan yli 200 €:n tilauksille Black Weeksin aikana
  • DHL seurannalla
  • Huomaamaton pakkaus

4.6/5 Trustpilotissa73 arvostelua

Haettu myös nimellä: Dutasterid

Yhdellä silmäyksellä

Dutasteride lukuina

Tietopankkimme keskeiset luvut. Vedä pistettä käyrää pitkin nähdäksesi, paljonko yhden annoksen jälkeen on laskennallisesti jäljellä.

Koko tietopankkiartikkeli

How long does it stay in the body?

Share left after one dose, calculated with a half-life of ~5 weeks

Half-life ~5 weeks
After 10 weeks: 25 %
Week 550 %Week 1025 %Week 1512.5 %Week 253.1 %

Simplified model without an absorption phase, half-life from the TPD lexicon.

Half-life

about5weeks

Class
5α-reductase inhibitor type 1 and type 2
Use
Oral1 tablet per day or every other day
Sizes
1 mg1 size in the shop

Tietoa

Kaikki aiheesta Dutasteride

FAQ

Usein kysyttyä

Lähteet jokaiseen vastaukseen: tietopankkiartikkeli

Onko sinulla vielä kysyttävää?

Kirjoita meille, tiimimme auttaa sinua.

Is dutasteride approved?

Yes. In the USA it has been approved as a prescription drug for the enlarged prostate since 20 November 2001, ChEMBL lists phase 4 as the highest phase. In hereditary hair loss it is used outside this approval, there are phase 3 trials on this.

How does dutasteride differ from finasteride?

Finasteride blocks only 5-alpha reductase type 2, dutasteride both types. In a comparison trial in men with enlarged prostate blood DHT fell by 94.7 percent with the approved dose of dutasteride and by 70.8 percent with finasteride. With finasteride the values also varied much more.

What do the hair loss trials show?

The first trial with 416 men already showed more hair in a dose-dependent way, the highest dose beat finasteride. In a trial with 917 men the approved dose grew more and thicker hairs after 24 weeks than finasteride and placebo. In a Korean phase 3 trial hair count rose by 12.2 per square centimetre in 6 months, on placebo by 4.7. All trials lasted at most 6 months.

What does research show for the prostate?

In three identical trials with 4,325 men the prostate shrank by 25.7 percent in 24 months, symptoms fell by 21.4 percent and urine flow rose. The risk of acute urinary retention fell by 57 percent, of surgery by 48 percent. In the CombAT trial the combination with tamsulosin worked better on symptoms over 4 years than either drug alone.

Does dutasteride lower prostate cancer risk?

In the 4-year REDUCE trial prostate cancer was found less often on dutasteride, 22.8 percent less in relative terms. Aggressive tumours with Gleason 8 to 10, however, were more common in years 3 and 4, 12 against 1. The composite term heart failure was also more common at 0.7 against 0.4 percent.

Which side effects have been described?

In the prostate trials impotence, reduced libido, breast enlargement and ejaculation disorders occurred more often than on placebo, but rarely overall. Except for breast enlargement they became less frequent over time. A meta-analysis in hair loss found a 1.37-fold risk of sexual side effects for dutasteride, not statistically significant. In direct comparison with finasteride there was no clear difference.

Vertailut

Miten se vertautuu

Liittyvät

Samankaltaiset tuotteet